Welcome to our dedicated page for B & G Foods SEC filings (Ticker: BGS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
B&G Foods, Inc. filings document the reporting obligations of a Delaware packaged-food company with common stock listed on the New York Stock Exchange under BGS. Form 8-K reports cover operating results, Regulation FD disclosures, completed asset acquisitions, executive departures, separation arrangements and other material events tied to its branded food portfolio.
Proxy materials describe director elections, executive compensation votes, auditor ratification and annual-meeting procedures. The filing record also identifies capital-structure details such as common stock par value, exhibits, Inline XBRL cover-page data and material agreements related to portfolio transactions, including the College Inn and Kitchen Basics acquisition.
B&G Foods, Inc. completed a private offering of $475.0 million aggregate principal amount of 11.00% senior notes due 2031, issued at 97.67% of face value. Interest is payable on June 15 and December 15 each year, starting December 15, 2026, with final maturity on June 15, 2031.
The company intends to use the net proceeds, together with borrowings under its revolving credit facility and cash on hand, to redeem all $509.3 million of its outstanding 5.25% senior notes due 2027 and pay related fees and expenses. The new notes are unsecured senior obligations guaranteed on a senior unsecured basis by certain domestic subsidiaries, include change-of-control repurchase rights, and are governed by an indenture with customary covenants and events of default.
B&G Foods, Inc. has priced an offering of $475.0 million in 11.00% senior notes due 2031 in a private transaction exempt from registration. The notes are being issued at 97.67% of face value and will be guaranteed on a senior unsecured basis by certain domestic subsidiaries.
The company expects the offering to close on June 10, 2026, subject to customary conditions, and estimates net proceeds of about $456.3 million. B&G Foods intends to use these proceeds, together with borrowings under its revolving credit facility and cash on hand, to redeem all $509.3 million of its outstanding 5.25% senior notes due 2027 and to pay related fees and expenses.
Brunts DeAnn L reported acquisition or exercise transactions in this Form 4 filing.
B&G Foods director DeAnn L. Brunts received a stock grant as part of her board compensation. On this Form 4, she was awarded 26,915 shares of Common Stock at no cash cost, representing an annual equity grant of approximately $130,000 based on a 30-day average closing price.
Following this award, she directly owns 110,838 shares. This is a routine, compensation-related equity grant to a non-employee director, not an open-market purchase or sale.
B&G Foods director Debra M. Chase received a grant of 26,915 shares of Common Stock on June 1, 2026. The shares were awarded at no cash cost as a stock grant, categorized as a grant, award, or other acquisition.
After this transaction, Chase directly holds 87,456 shares of B&G Foods Common Stock. A footnote explains that each non-employee director receives an annual equity grant of approximately $130,000 of Common Stock, based on a 30-day average closing price, as part of director compensation.
B&G Foods, Inc. director Charles F. Marcy reported an acquisition of Common Stock through an equity grant. He received 26,915 shares of Common Stock at $0.0000 per share, described as part of the approximately $130,000 annual equity grant for non-employee directors based on a 30-day average closing price.
Following this grant, Marcy directly holds 122,636 shares of Common Stock. A separate entry shows 14,884 shares held indirectly through his wife, reported as a holding entry rather than a new transaction. The filing shows compensation-related share awards, with no open-market buys or sells.
Mills Robert D reported acquisition or exercise transactions in this Form 4 filing.
B&G Foods director Robert D. Mills reported receiving an equity grant of 26,915 shares of Common Stock on June 1, 2026. The grant was awarded at no cash cost to him as a compensation-related award, not an open-market purchase.
According to the disclosure, each non-employee director receives an annual equity grant of approximately $130,000 in Common Stock based on a 30-day average closing price. Following this grant, Mills directly holds 99,656 shares, indicating this is a routine board compensation grant rather than a change in investment stance.
Mullen Dennis M reported acquisition or exercise transactions in this Form 4 filing.
B&G Foods, Inc. director Dennis M. Mullen received a grant of 26,915 shares of Common Stock on June 1, 2026 as part of his non-employee director compensation. The annual equity grant is approximately $130,000 based on a 30-day average closing price. Following the award, he directly owns 110,871 shares.
B&G Foods director Cheryl M. Palmer received a stock grant as part of her board compensation. On this Form 4, she acquired 26,915 shares of common stock at a stated price of $0.00 per share as a grant or award, not an open-market purchase.
Following the grant, Palmer directly holds 107,136 shares of B&G Foods common stock. A footnote explains that each non-employee director receives an annual equity grant of approximately $130,000 of common stock, based on a 30-day average closing price, as part of director compensation.
POE ALFRED reported acquisition or exercise transactions in this Form 4 filing.
B&G Foods director Alfred Poe received an equity grant of 26,915 shares of Common Stock as part of his non-employee director compensation. The grant was valued at approximately $130,000, based on a 30-day average closing price. Following this award, Poe directly owns 107,596 shares of B&G Foods common stock.
B&G Foods director Stephen Sherrill reported compensation-related stock awards, not open-market trades. He received a grant of 26,915 shares of Common Stock at no cost, bringing his direct holdings to 404,666 shares. He was also granted stock options for 189,111 shares of Common Stock at an exercise price of $3.99 per share, exercisable beginning on June 1, 2027 and expiring on June 1, 2036. Footnotes explain that non-employee directors receive an annual equity grant of approximately $130,000 in stock and that Sherrill elected to receive all $165,000 of his annual board service fee in the form of options instead of cash.